Maravai LifeSciences Holdings, Inc. MRVI Cygnus — Adjusted EBITDA for reportable segments

Similar metrics at other companies

TKREngineered Bearings — Adjusted EBITDA for reportable segments

$159M-0.1%

TKRIndustrial Motion — Adjusted EBITDA for reportable segments

$91.3M+36.1%

LUMNReportable Segment — Adjusted EBITDA

$1.28B+54.1%

OTEXReportable Segment — Adjusted EBITDA

$506.65M+14.1%

CRONReportable Segment — Adjusted EBITDA

$13.09M+675%

LAMRReportable Segment — Adjusted EBITDA

$303.51M+9.0%

FAQ

What is Maravai LifeSciences Holdings, Inc.'s cygnus — adjusted EBITDA for reportable segments?

Maravai LifeSciences Holdings, Inc. (MRVI) reported cygnus — adjusted EBITDA for reportable segments of $11.38M in Q2 2026.

How has Maravai LifeSciences Holdings, Inc.'s cygnus — adjusted EBITDA for reportable segments changed year-over-year?

Maravai LifeSciences Holdings, Inc.'s cygnus — adjusted EBITDA for reportable segments increased by 4.7% year-over-year, from $10.86M to $11.38M.

What does cygnus — adjusted EBITDA for reportable segments mean?

Measures the core operational profitability of the Cygnus segment by excluding interest, taxes, depreciation, amortization, and non-recurring charges. This metric provides a normalized view of the segment's ability to generate cash flow from its primary business activities, facilitating performance comparisons across different reporting periods.